Back

11 June 2023

Reducing colorectal cancer risk in IBD

4_Hilmi-solo.jpg

Welcome to the BSG Global Grand Rounds, brought to you by the International Section of the BSG.

This webinar series aims to cover the SCE curriculum with speakers from across the globe giving us an international perspective on common gastro- intestinal conditions.


Learning points

  • Managing inflammation aggressively reduces colorectal cancer risk 
  • Surveillance is required, especially in high-risk groups 
  • High quality histopathology services are required to support clinical decisions 

About our speakers

Prof Ida Hilmi, Consultant Gastroenterologist, University of Malaya

  • Head of the Department of Medicine
  • Immediate past Head of Division in Gastroenterology and Hepatology and Director of Endoscopy
  • Co-founder and first Chairman of the Malaysian Inflammatory Bowel Disease Special Interest Group (IBD-SIG)
  • Committee member Malaysian National Training Board in Gastroenterology and Hepatology.
  • Member of IBD-Emerging Nations Consortium, International scientific committee member for Asian Organization of Crohn’s and Colitis (AOCC) Congress
  • Subspecialty include IBD and colorectal cancer screening

Dr Ibrahim Al Bakir, Consultant Gastroenterologist, Chelsea and Westminster Hospital

Dr Ibrahim Al Bakir is a Consultant Luminal Gastroenterologist at Chelsea and Westminster Hospital. He qualified from Oxford University, and completed specialist training in Gastroenterology in the Northwest London region. During his training, Dr Al-Bakir was awarded a MRC fellowship to undertake a PhD at Barts Cancer Institute and St Mark’s Hospital on the identification of molecular and genetic signatures that can stratify patients with inflammatory bowel disease by future colorectal cancer risk. He has presented his work on IBD surveillance at international conferences, widely published peer reviewed papers and several book chapters. Dr Al Bakir is an elected member of the colorectal section of the British Society of Gastroenterology. 

Dr Johanne Brooks-Warburton, Consultant Gastroenterologist, East & North Hertfordshire NHS Trust

Jo is a less than full time academic gastroenterologist with a specialist interest in Inflammatory Bowel Disease (IBD) and the IBD Lead at Lister Hospital, Stevenage, UK.  She runs the IBD ‘hot’ clinic and the IBD-Rheumatology-Dermatology-Hepatology MDT. She is PI to all the IBD Clinical and Commercial trials at Lister Hospital and sits on the Research and Development Steering Group for the East and North Hertfordshire Trust. As a senior lecturer at the University of Hertfordshire, she lectures on the Physician Associate Masters, and supervises PhD and MD students in IBD related research, as well as having her own research group.  Her latest publication, in Nature Communications, was using systems genomics to uncover patient specific pathogenic pathways in ulcerative colitis https://doi.org/10.1038/s41467-022-29998-8. She has published in allied subjects, looking at the role of artificial Intelligence in the IBD patient journey, and continues to drive this agenda forward in her role as the Deputy Lead of BSG IBD Subgroup of the Artificial Intelligence Workforce. Before joining the Lister Team, she completed her IBD Advanced Training and Gastro training locally in the Eastern Deanery, receiving hospital wards for her patient care, and was the trainee rep and then the academic trainee rep for the deanery. She has continued this representation on the other side of the table, being the co-academic lead for the Gastroenterology Training Program and the Academic Representative on the BSG Supporting Women in Gastroenterology Committee and the BSG Research Committee. She is very vocal in support of all types of research within gastroenterology and was recently a panelist for the Frontline Gastroenterology Twitter Debate: Research. To do or not to do? September 20th 2022. She is an academic representative on BSG SWIG and has newly been elected to the BSG IBD Clinical Research Group.